MARKET WIRECNBC • 1h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why DBD Stock advanced +1.84% Today — RQD Quant Desk Flash
$59.14 +1.84% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
Diebold Nixdorf Incorporated (DBD) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.
ROARABLE C- • HOLD / WATCH
Cap $1.99B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C-
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw C- · Rk C
Each axis scored 0–20
12M PRICE TARGET CONE+1.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DBD)Realized 20D OHLCV Swing Band: ±8.5%
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why DBD Stock advanced +1.84% Today — RQD Quant Desk Flash
Diebold Nixdorf Incorporated (DBD) advanced +1.84% to $59.14, trading at 16% of its 52-week range ($52.87 – $92.09). Solid 25% profit margin (12% return on capital), mixed timing at 21x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 16% of its 52-week range ($52.87 – $92.09) with RSI-14 at 27.7 (OVERSOLD (<32)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±8.5% around $59.14 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 25.3% gross margin and $300.7M annual free cash flow.
Live DBD Headlines & Catalysts
MARKET WIRECNBC • 2h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 3h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 4h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 5h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 6h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 6h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 6h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (DBD Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
DBD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -23.00%📐 HORIZONTAL RANGE
2026-10-30O $58.39H $59.14L $52.87C $59.14VOL 739.9K
RES: $105.4SUP: $53.42SMA50: $65.15SMA200: $74.96
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
DBD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
14.6%/yr Implied 5Y Growth
vs. +1.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on DBD today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for DBD. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DBD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DBD)
Industrials Rank #153 of 485
⚔️ PBI vs DBD Full Matrix →
1. Head-to-Head Industrials Peer Comparison (DBD vs. PBI, NATL, VYX, PAR)
Industry: Office Equipment/Supplies/Services (13 Tracked Issuers)Across 485 tracked Industrials securities in the Roarable RQD universe, Diebold Nixdorf Incorporated (DBD) ranks #153 by composite RQD confidence (61/100, grade C-) and #211 by equity capitalization ($1.99B). Within this direct 5-issuer industry benchmark cohort, PBI leads on earnings valuation at 15.6x trailing P/E, while NATL leads on capital efficiency and profitability with 14.4% ROIC and — gross margin. PBI currently holds the highest overall quantitative score in the immediate peer group at 66/100 (C+) compared with DBD at 61/100 (C-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| DBD
ACTIVE
Diebold Nixdorf Incorporated | C- | 61/100 | 21.0x | 25.3% | 11.5% | +1.84% | $1.99B | Benchmark Subject |
| PBI Pitney Bowes Inc. | C+ | 66/100 | 15.6x | — | — | -5.62% | $2.26B | /pbi-vs-dbd → |
| NATL NCR Atleos Corporation | D+ | 56/100 | 20.9x | — | 14.4% | +0.93% | $3.38B | /natl-vs-dbd → |
| VYX NCR Voyix Corporation | E | 31/100 | 18.3x | — | 1.1% | +3.27% | $1.13B | /vyx-vs-dbd → |
| PAR PAR Technology Corporation | E | 31/100 | — | 43.5% | -4.9% | +3.55% | $736.3M | /par-vs-dbd → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000028823In its most recent audited fiscal period (FY2025, filed 2025-12-31), Diebold Nixdorf Incorporated (DBD) reported GAAP revenue of $3.81B (+1.5% vs. FY2024 revenue of $3.75B ) , GAAP net income of $94.6M, operating cash flow of $300.7M, and free cash flow of $300.7M (+101.5% YoY). On the balance sheet, DBD closed FY2025 with $3.85B in total assets against $938.5M in total debt (Altman Z-Score: 1.79, Piotroski F-Score: 8/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $3.81B | $94.6M | $300.7M | $300.7M | $3.85B | $938.5M |
| FY2024 (FY) | 2024-12-31 | $3.75B | -$16.5M | $149.2M | $149.2M | $3.54B | $927.3M |
3. DBD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs DBD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Diebold Nixdorf Incorporated (NYSE: DBD) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $59.14 (+1.84% 1D, market cap $1.99B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 16/20. Across 485 tracked Industrials issuers, DBD ranks #153 in composite RQD confidence.
How does DBD compare to PBI and NATL in the Industrials sector?
Within the Industrials sector (Office Equipment/Supplies/Services), DBD carries a Roarable C- (61/100 RQD), trailing P/E of 21.0x, gross margin of 25.3%, and ROIC of 11.5%. By comparison, PBI (Pitney Bowes Inc.) holds a C+ grade (66/100 RQD, P/E 15.6x, ROIC —, cap $2.26B) and NATL (NCR Atleos Corporation) posts a D+ grade (56/100 RQD, P/E 20.9x, ROIC 14.4%, cap $3.38B). Among the 5-stock peer group, PBI leads on earnings multiple (15.6x) while NATL leads on capital efficiency (14.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for DBD?
Per DBD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000028823), Diebold Nixdorf Incorporated generated $3.81B in revenue (+1.5% YoY), $94.6M in net income, and $300.7M in free cash flow against $3.85B in total assets and $938.5M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is DBD trading relative to its 50-day, 200-day, and 52-week technical levels?
DBD last traded at $59.14 (+1.84% on volume of 685,821 shares), positioning the stock -9.22% below its 50-day simple moving average ($65.15) and -21.10% below its 200-day simple moving average ($74.96). Across its 52-week range of $52.87 to $92.09, DBD sits at the 16.0% percentile with a 14-day RSI of 27.7 (OVERSOLD (<32)) and an implied next-earnings move of ±8.5% ($54.11 to $64.17).
DBD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is DBD stock moving today?
Why DBD Stock advanced +1.84% Today — RQD Quant Desk Flash. Solid 25% profit margin (12% return on capital), mixed timing at 21x P/E—hold if owned, no rush to chase.